Health and Fitness Health and Fitness
Tue, November 23, 2010
[ Tue, Nov 23rd 2010 ] - Market Wire
Vascular Solutions to Present at the 5th Annual C .. y Cardiovascular, Diabetes and Obesity Conference
[ Tue, Nov 23rd 2010 ] - Market Wire
Alnylam to Webcast Presentation at Piper Jaffray 22nd Annual Healthcare Conference
[ Tue, Nov 23rd 2010 ] - Market Wire
IR Global Rankings Announces Agreement with Institutional Investor for its IR Global Events
[ Tue, Nov 23rd 2010 ] - Market Wire
Clinical Data, Inc. to Present at the 22nd Annual Piper Jaffray Health Care Conference
[ Tue, Nov 23rd 2010 ] - Market Wire
GlaxoSmithKline and Dr. Reddya?s Agree to the Sale of US Penicillin Facility and Products
[ Tue, Nov 23rd 2010 ] - Market Wire
New Report Shows Half the Country Could Have Diab .. r Prediabetes at a Cost of $3.35 Trillion by 2020
[ Tue, Nov 23rd 2010 ] - Market Wire
Imaging Diagnostic Systems Installs Its CTLM® in Israel
[ Tue, Nov 23rd 2010 ] - Market Wire
CHINA HEALTH LABS &; DIAGNOSTICS LTD. ANNOUNCES CONTRACT TO SUPPLY 17 MOBILE FOOD SAFETY LABS
[ Tue, Nov 23rd 2010 ] - Market Wire
Norton Healthcare and Humana Launch Accountable Care Organization in Louisville, Ky.
[ Tue, Nov 23rd 2010 ] - Market Wire
Abiomed to Present at 22nd Annual Piper Jaffrey Healthcare Conference
[ Tue, Nov 23rd 2010 ] - Market Wire
Anika Therapeutics to Present at NYSSA Biotech and Specialty Pharmaceuticals Conference
[ Tue, Nov 23rd 2010 ] - Market Wire
ZIOPHARM Oncology to Present at the 22nd Annual Piper Jaffray Health Care Conference
[ Tue, Nov 23rd 2010 ] - Market Wire
Gilead Sciences Submits New Drug Application to U .. le-Tablet Regimen of Truvada® and TMC278 for HIV
[ Tue, Nov 23rd 2010 ] - Market Wire
XenoPort Awarded Grant from The Michael J. Fox Foundation
[ Tue, Nov 23rd 2010 ] - Market Wire
St. Jude Medical Announces Final Results of its Exchange Offer for AGA Medical
[ Tue, Nov 23rd 2010 ] - Market Wire
Affymax to Webcast Analyst Briefing on Hematidea"/Peginesatide Development Program
[ Tue, Nov 23rd 2010 ] - Market Wire
Vertex Completes New Drug Application for Telaprevir for Hepatitis C
[ Tue, Nov 23rd 2010 ] - Market Wire
Unigene Completes Executive Management Team and N .. f Investor Relations and Corporate Communications
[ Tue, Nov 23rd 2010 ] - Market Wire
Northstar Healthcare Announces Results of TSX Continued-Listing Review
[ Tue, Nov 23rd 2010 ] - Market Wire
Somaxon Pharmaceuticals to Present at Piper Jaffray 22nd Annual Healthcare Conference
[ Tue, Nov 23rd 2010 ] - Market Wire
Covidien to Present at Piper Jaffray Health Care Conference
[ Tue, Nov 23rd 2010 ] - Market Wire
Salix Pharmaceuticals to Present at Piper Jaffray Conference
[ Tue, Nov 23rd 2010 ] - Market Wire
UnitedHealthcare Introduces Pharmacy Saver for Medicare Plan Members
[ Tue, Nov 23rd 2010 ] - Market Wire
SuperGen to Present at New York Society of Securi .. ialty Pharmaceuticals Conference on November 30th
[ Tue, Nov 23rd 2010 ] - Market Wire
Santarus to Present at Piper Jaffray 22nd Annual Health Care Conference
Mon, November 22, 2010
[ Mon, Nov 22nd 2010 ] - Market Wire
Shanghai ChemPartner Receives Award of Excellence from Genzyme
[ Mon, Nov 22nd 2010 ] - Market Wire
Palo Alto Investors Calls on Board of AMAG Pharma .. to Repurchase Stock and Increase Stockholder Valu
[ Mon, Nov 22nd 2010 ] - Market Wire
Medtronic Signs Agreement to Acquire Ardian
[ Mon, Nov 22nd 2010 ] - Market Wire
Medical Facilities Corporation Announces Approval .. for Debentures and Automatic Securities Purchase
[ Mon, Nov 22nd 2010 ] - Market Wire
Biogen Idec Announces Webcast of Neurodegeneration & Repair R&D Roundtable

Biogen Idec Announces Webcast of Neurodegeneration & Repair R&D Roundtable


Published on 2010-11-22 13:35:34 - Market Wire
  Print publication without navigation


WESTON, Mass.--([ BUSINESS WIRE ])--Biogen Idec Inc. (NASDAQ: BIIB) announced today that its Neurodegeneration & Repair R&D Roundtable will be webcast live on Tuesday, November 30, 2010 at 11:30 a.m. ET. To access the live webcast, please visit Biogen Ideca™s Investor Relations section (investor.biogenidec.com). An archived version of the webcast will be available for 14 days following the presentation.

About Biogen Idec

Biogen Idec uses cutting edge science to discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $4 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit [ www.biogenidec.com ].

Contributing Sources